Armata Pharmaceuticals, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001558370-25-011235
- Form type
- 10-Q
- CIK
- 0000921114
- Primary document
- https://www.sec.gov/Archives/edgar/data/921114/000155837025011235/armp-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Armata Pharmaceuticals, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-15.0M | - | - |
| Net Income | $-22.8M | - | - |
| Eps Basic | -0.63 | - | - |
| Eps Diluted | -0.63 | - | - |
| Cash And Equivalents | $4.3M | - | - |
| Total Assets | $80.8M | - | - |
| Total Liabilities | $150.3M | - | - |
| Shareholders Equity | $-69.5M | - | - |
| Operating Cash Flow | $-14.8M | - | - |
| Capital Expenditures | $248,000 | - | - |